Publications by authors named "E Kayson"

Claim this Profile
P
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trial.
Ralf Reilmann, Andrew Feigin, Anne E Rosser, Sandra K Kostyk, Carsten Saft, Elise Kayson

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Deutetrabenazine at High versus Lower Daily Dosages in the ARC-HD Study to Treat Chorea in Huntington Disease.
Samuel Frank, Claudia M Testa, Jody Goldstein, Elise Kayson, Blair R Leavitt

CNS Drugs· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Huntington's Disease Patients Say About Their Illness: An Online Direct-to-Participant Pilot Study.
Karen E Anderson, Lakshmi Arbatti, Abhishek Hosamath, Andrew Feigin, Jody Goldstein, Elise Kayson

J Huntingtons Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial.
Erin Furr Stimming, Daniel O Claassen, Elise Kayson, Jody Goldstein, Raja Mehanna

Lancet Neurol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.
Samuel Frank, Claudia Testa, Mary C Edmondson, Jody Goldstein, Elise Kayson

CNS Drugs· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis